Index
Module 4 • Quality & Safety
Protocol Development & Quality Improvement
70%
Data Tables
Protocol Development & Quality Improvement
Jaime Robenolt Gray ~3 min read Module 4 of 20
31
/ 44

Protocol Development and Quality Improvement

5

Both methods should be available for documenting pharmacotherapeutic interventions, and criteria

should be established to determine which method is most appropriate.

6

Pharmacists should have the authority to document pharmacotherapeutic interventions in the EHR.

7

Pharmacists should be trained and educated to document in the EHR. The ASHP Clinical Skills

Certificate program is a tool that can be used to train pharmacists to document in the EHR.

8

Documentation methods may include standard format documentation methods such as:

SOAP (subjective, objective, assessment, plan)

TITRS (title, introduction, text, recommendation, signature)

FARM (findings, assessment, resolution, monitoring)

9

Wording for solicited consultations should be direct. Unsolicited pharmacist interventions should be

documented subtly, allowing the primary provider to decline the recommendation without incurring

liability. Phrases that can be used include:

β€œMay consider”

β€œSuggest”

β€œMay recommend”

10When feasible, written notes by pharmacists should be documented in the EHR after an oral

communication with the clinician; this allows for any patient data discrepancies to be corrected and

for agreement and confirmation between the prescriber and the pharmacist to execute the intervention.

11Pharmacists should follow up on their patient interventions daily and provide follow-up notes that

include patient progress or new interventions, when needed.

Pharmacists should provide their contact information.

Co-signatures should be required for pharmacy residents (until deemed competent according to

pharmacy department standards), interns, and students.

Continual physical presence during and after direct patient care rounds should be provided to

support the physicians, advanced practice providers, and nursing team with triaging medication-

related questions.

12Many web-based or handheld electronic systems are available that can be used to document and report

pharmacotherapeutic interventions and cost savings. Ideally, these are documented in the patient’s EHR

for the reporting of weighted metrics.

Patient Case

8

During ICU rounds, the team is recommending a cost-prohibitive non-formulary drug with controversial

outcomes as a last line vasopressor for a patient with septic shock. You review the chart and think there

are safer formulary options to try before resorting to this new therapy. You are required to document your

interventions in the patient chart for tracking purposes. Which wording is the most appropriate to use?

A.Because of the significant cost of this drug, the team should resort to other formulary options.
B.This drug was associated with significant adverse effects in clinical trials and will likely cause harm if

used in this patient.

C.The team should consider optimizing the patient’s pharmacological therapy with agents that are on

formulary and have a proven benefit in patients with septic shock.

D.The use of this non-formulary drug would be a poor choice and likely lead to patient harm if used.
Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 30 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube